Step by Step


ABIM MOC Activity ID

10/24/2023 - Medical Grand Rounds: Obesity Medicine Year in Review





Credit Hours: CME 1.00

Target Audience:

Faculty, residents, fellows, and community physicians in General Internal Medicine and subspecialties.

Educational Objectives:

Upon completion of this activity, participants should be able to:

    • Apply new evidence-based treatments from the literature to manage obesity and weight related co-morbidities, and provide average weight results of different therapies.
    • Summarize recent studies and their practical applications for the treatment of obesity in plain language for use in communication with patients.  
    • Review new treatments in the pipeline for obesity.
    • Incorporate a multi-disciplinary treatment approach to obesity after review of literature that includes updates and advances in lifestyle modifications, pharmacotherapy, and surgical interventions

Suggested Additional Reading & Joint Accreditation Statement - Note: This Accreditation Statement Supersedes All Other Statements:

  1. Wharton S, Batterham RL, Bhatta M, et al. Two-year effect of semaglutide 2.4 mg on control of eating in adults with overweight/obesity: STEP 5. Obesity (Silver Spring). 2023 Mar;31(3):703-715. 
  2. Frias JP, Deenadayalan S, Erichsen L,  et al. Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial. Lancet. 2023 Aug 26;402(10403):720-730. 
  3. Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial AuBarham K Abu Dayyeh MD, Fateh Bazerbachi MD, Eric J Vargas MD,  et al. MERIT Study Group
  4. Visaria A, Setoguchi S (2023) Body mass index and all-cause mortality in a 21st century U.S. population: A National Health Interview Survey analysis. PLoS ONE 18(7): e0287218. 
  5. Murvelashvili N, Xie L, Schellinger JN, et al. Effectiveness of semaglutide versus liraglutide for treating post-metabolic and bariatric surgery weight recurrence. Obesity (Silver Spring). 2023 May;31(5):1280-1289.
  6. Adrian F Bogh, Simon B K Jensen, Christian R Juhl, et al. Insufficient sleep predicts poor weight loss maintenance after 1 year, Sleep, Vol 46, Issue 5, May 2023

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician (CME)

The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credits™.Each physician should only claim credit commensurate with the extent of their participation in the activity.

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

David Rometo, MD — Clinical Assistant Professor of Medicine
Division of Endocrinology and Metabolism
Clinical Lead, Endocrine Obesity Unit and Weight, University of Pittsburgh School of Medicine
Dr Rometo disclosed he was a Nestle Health Science, one-time advisory board participant, November 2021
Noor Khan, MD — Associate Program Director, Obesity Medicine Fellowship Program, University of Pittsburgh
No planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

This activity is approved for AMA PRA Category 1 Credit™

The University of Pittsburgh is an affirmative action, equal opportunity institution.